2011
DOI: 10.1590/s0102-76382011000100011
|View full text |Cite
|
Sign up to set email alerts
|

Trombocitopenia em cirurgia cardíaca: importância diagnóstica e prognóstica

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 30 publications
1
2
0
Order By: Relevance
“…for post-operative determinants, thrombocytopenia and IABP were associated with 30-day mortality after CABG. Post-operative thrombocytopenia increased the risk of 30-day mortality after CABG by 3.99-fold, consistent with the results of the previous studies by Kertai et [20], [21], [22]. Moreover, determinants such as the duration of aortic clamping, cardiopulmonary bypass, and post-operative IABP were previously reported to increase the risk of thrombocytopenia [20].…”
Section: Assupporting
confidence: 89%
“…for post-operative determinants, thrombocytopenia and IABP were associated with 30-day mortality after CABG. Post-operative thrombocytopenia increased the risk of 30-day mortality after CABG by 3.99-fold, consistent with the results of the previous studies by Kertai et [20], [21], [22]. Moreover, determinants such as the duration of aortic clamping, cardiopulmonary bypass, and post-operative IABP were previously reported to increase the risk of thrombocytopenia [20].…”
Section: Assupporting
confidence: 89%
“… 1 There is a risk of developing thrombocytopenia in 35–65% of the patients who undergo cardiac surgery. 2 …”
Section: Introductionmentioning
confidence: 99%
“…In the general intensive care unit (ICU) scenario, thrombocytopenia may occur in up to 20% admissions, 35% of surgical hospitalizations and 45% of trauma admissions [1] . Considering cardiac surgery patients, thrombocytopenia is an extremely frequent finding, varying from 35% to 65% of all cases [10] , and patients after percutaneous coronary interventions (PCI) are also prone to develop major thrombocytopenia, i.e . <100.000/µL, in 2.4-9.2% of cases [11-13] .…”
Section: Introductionmentioning
confidence: 99%